4
Changes in Ownership
AbCellera Biologics Inc. Filed Acc 0000899243-21-022894
Chief Financial Officer acquired 1,200,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Booth Andrew Chief Financial Officer | 2021-06-07 | Option exercise | +600,000 | $0.19 | $114,000 | 600,000 | D |
| Booth Andrew Chief Financial Officer | 2021-06-07 | Option exercise | +600,000 | $0.32 | $192,000 | 1,200,000 | D |
| Derivatives | |||||||
| Booth Andrew Chief Financial Officer | 2021-06-07 | Option exercise · Share Option (right to buy) | −600,000 | 300,000 | D | ||
| Booth Andrew Chief Financial Officer | 2021-06-07 | Option exercise · Share Option (right to buy) | −600,000 | 4,950,000 | D | ||
Loading xslF345X03/doc4.xml…